Follow-The-Filings

Security

BBIO

Bridgebio Pharma Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

17 owners 3 new max 4.0% (Farallon Capital Manageme...)

grid → activity →
owners 17
max % 4.0%
tracked value $3.7B
qoq N 3 A 11 R 1

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Farallon Capital Management LLC 2026 Q1 4.0% Add +0.72 pp 9,365,463 $695M hist
Andreas Halvorsen - Viking Global Investors LP 2026 Q1 2.5% Reduce -0.46 pp 11,842,434 $879M hist
Two Sigma Investments, LP 2025 Q4 stale 0.2% Exit -0.21 pp 1,947,047 $149M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.1% Add +0.02 pp 2,545,486 $189M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.1% Add +0.07 pp 259,459 $19M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add +0.03 pp 3,173,940 $236M hist
Renaissance Technologies LLC 2026 Q1 0.0% New 0.0% 365,772 $27M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Add +0.01 pp 350,096 $26M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add +0.01 pp 16,862,691 $1.3B hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add +0.02 pp 633,283 $47M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add +0.02 pp 334,382 $25M hist
Polen Capital Management LLC 2026 Q1 0.0% Add +0.01 pp 45,934 $3M hist
Norges Bank 2025 Q4 stale 0.0% Exit -0.01 pp 1,527,028 $117M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 351,628 $26M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 160,112 $12M hist
Natixis Advisors, LLC 2026 Q1 0.0% New 0.0% 21,070 $2M hist
Ancora Advisors LLC 2026 Q1 0.0% New 0.0% 100 $7 hist

17 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $9.3M $221.9M $502.08M
Gross profit * $6.86M $218.02M $481.11M
Gross margin * 73.7% 98.3% 95.8%
Net income — — —
Net margin — — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $477.59M $720.69M $797.75M
Total non-current assets * $68.79M $198.65M $138.28M
Total assets $546.38M $919.34M $936.02M
Total current liabilities $143.84M $154.4M $287.97M
Total non-current liabilities * $1.75B $2.22B $2.72B
Total equity -$1.35B -$1.47B -$2.09B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$527.72M -$520.73M -$445.91M
Cash from investing $54.03M $60.78M -$24.49M
Cash from financing $451.54M $748.46M $359.29M
Net change in cash -$22.15M $288.51M -$111.1M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders